Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2016

Dec 30, 2016

30870_dirs_2016-12-30_dc0ccdaa-5f17-4bd4-87c2-6caea5f1c6a3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2016-12-28

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-28 Common Stock S 2307 $12.31 Disposed 3361 Direct
2016-12-28 Common Stock S 200 $12.305 Disposed 3161 Direct
2016-12-28 Common Stock S 1800 $12.3236 Disposed 1361 Direct
2016-12-29 Common Stock S 1326 $12.519 Disposed 35 Direct